The single-arm, open-label DR-OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who are at risk for pregnancy or desiring contraception.

The new method, which is illegal in the United States but approved in Britain since 2015, adds a tiny bit of healthy mitochondrial DNA from a donor’s egg to the mix, with more than 99% of the child’s ...

Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

Researchers conducted an observational study to assess the effect of osteoporosis treatment on mortality risk among patients ...

After a transgender patient sued a nurse and a walk-in clinic for sex discrimination under the Affordable Care Act (ACA), as ...

Researchers analyzed hospital inpatient data to evaluate the risk for vascular events on the basis of PCOS among women with ...

Researchers compared radiologist performance and visual search patterns when reading screening mammograms with and without an AI decision support system.

There is limited research on chronic pelvic pain in men, which delays treatment for male patients experiencing symptoms of ...

The most prevalent symptom of discontinuation was dizziness, and, despite being measured in people with major depressive disorder, discontinuation was not associated with depression symptoms.

The population analysis included 99,411 women with premenstrual disorders, and the sibling analysis included 36,061 women with premenstrual disorders.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Researchers conducted the QWINT-1 and QWINT-2 clinical trials to assess glycemic and patient-reported outcomes among those using once-weekly insulin efsitora.